Crocs, Inc.
CROX
$135.39
-1.27%
Crocs, Inc. designs, develops, markets, and distributes casual lifestyle footwear and accessories for men, women, and children, operating through its Crocs Brand and HEYDUDE Brand segments. The company is a distinctive player in the apparel-footwear industry, known for its iconic clog and a strong direct-to-consumer model, though it faces challenges integrating its HEYDUDE acquisition. Currently, the investor narrative centers on a brand recovery story, with Crocs' core business showing resilience while the market debates the turnaround potential of HEYDUDE and the stock's attractive valuation after recent analyst upgrades.…
CROX
Crocs, Inc.
$135.39
Related headlines
Investment Opinion: Should I buy CROX Today?
Rating: Hold. Crocs is a compelling value play with a low forward P/E and strong cash flow, but declining revenue and analyst downside targets warrant caution. The consensus rating is mixed (4 Buy, 4 Hold, 1 Sell) with an average target of $126, implying 8% downside from current levels.
Supporting evidence: The forward P/E of 9.4x is well below the historical range and the PEG ratio of 0.52 suggests undervaluation. Revenue declined 1.7% YoY in Q1 2026, but gross margin remains healthy at 56.8% and operating margin is 21.8%. Free cash flow TTM of $670.7 million provides a 14.5% yield. The stock has strong momentum, up 28.6% over the past year, but the average analyst target implies limited upside.
Risks & Conditions: The Hold rating would upgrade to Buy if HEYDUDE shows sustained improvement or if the stock pulls back to $126 (analyst average) or below, offering a better entry. It would downgrade to Sell if revenue growth turns negative for multiple quarters or if gross margins fall below 55%. Overall, Crocs appears fairly valued relative to its earnings power but overvalued relative to analyst targets, making it a hold for now.
Sign up to view all
CROX 12-Month Price Forecast
Crocs presents a balanced risk/reward profile. The low valuation and strong cash flow provide a floor, but declining revenue and HEYDUDE uncertainty cap upside. The base case of a flat to slightly down stock over 12 months is most likely, with a 50% probability. A bullish outcome requires a successful HEYDUDE turnaround, while a bearish outcome could stem from macro weakness or brand failure. The neutral stance reflects the tension between value and growth concerns.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crocs, Inc.'s 12-month outlook, with a consensus price target around $128.08 and implied upside of -5.4% versus the current price.
Average Target
$128.08
0 analysts
Implied Upside
-5.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$86 - $160
Analyst target range
Crocs is covered by 12 analysts, with a consensus recommendation leaning bullish (recent upgrades from Piper Sandler, Baird, and Seaport Global). The average target price is $126.00, implying a -8.1% downside from the current price of $137.13. The distribution shows 4 Buy, 4 Hold, and 1 Sell (from Goldman Sachs), indicating mixed sentiment. The implied downside suggests the stock may be overvalued relative to analyst expectations. The target range spans from a low of $86.00 to a high of $150.00. The high target of $150 assumes successful HEYDUDE turnaround and margin expansion, while the low target of $86 reflects risks of continued brand struggles or recession. Recent upgrades from Piper Sandler (Overweight) and Baird (Outperform) contrast with Goldman Sachs' Sell rating, indicating divergent views. The wide spread ($64) signals high uncertainty about the company's future performance.
Drowning in data?
Find the real signal!
Bulls vs Bears: CROX Investment Factors
Crocs presents a classic value-versus-growth tension: the stock trades at a compelling forward P/E of 9.4x with strong free cash flow, but faces declining revenue and an uncertain HEYDUDE turnaround. The bull case rests on the low valuation and cash generation providing a safety net, while the bear case centers on top-line erosion and analyst targets suggesting downside. Currently, the evidence slightly favors the bull case given the PEG ratio of 0.52 and recent analyst upgrades, but the key swing factor is whether HEYDUDE can stabilize—if it does, the stock could re-rate higher; if not, the discount may persist or widen.
Bullish
- Low Forward P/E of 9.4x: Crocs trades at a forward P/E of 9.4x, well below the historical range of 4.3x-15.7x and the industry average. This discount implies the market is pricing in significant pessimism, offering a margin of safety if earnings stabilize.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow is $670.7 million, representing a free cash flow yield of approximately 14.5% relative to the market cap of $4.64 billion. This robust cash generation supports debt reduction and potential shareholder returns.
- PEG Ratio of 0.52 Suggests Undervaluation: The PEG ratio of 0.52 indicates the stock is undervalued relative to its expected earnings growth. Even modest growth would justify a higher multiple, making the current valuation attractive for value-oriented investors.
- Recent Analyst Upgrades Signal Confidence: Piper Sandler and Baird recently upgraded Crocs to Overweight and Outperform, respectively, citing brand recovery and attractive valuation. These upgrades from credible firms counterbalance the lone Sell rating from Goldman Sachs.
Bearish
- Revenue Declining Year-over-Year: Q1 2026 revenue of $921.5 million was down 1.7% YoY, following a pattern of deceleration from $1,149.4M in Q2 2025. The top-line contraction raises concerns about demand for both Crocs and HEYDUDE brands.
- Analyst Average Target Implies 8% Downside: The average analyst target of $126.00 is 8.1% below the current price of $137.13, suggesting the stock may be overvalued relative to consensus expectations. The wide target range ($86-$150) reflects high uncertainty.
- HEYDUDE Brand Turnaround Uncertain: HEYDUDE contributed only $154 million in Q1 2026, and the brand's struggles led to a large impairment in Q2 2025. The success of the turnaround plan is unproven, and failure could weigh on overall results.
- High Beta of 1.549 Amplifies Market Risk: With a beta of 1.549, Crocs is 55% more volatile than the market. In a downturn, the stock could decline significantly more than the S&P 500, amplifying losses for investors.
CROX Technical Analysis
Crocs is in a strong uptrend, with the stock price up 28.6% over the past year and currently trading at $137.13, near the top of its 52-week range ($73.21-$140.42) at approximately 97.7% of the high. This positioning near the 52-week high suggests bullish momentum, though it also raises caution about potential overextension. The 1-year price change of 28.6% significantly outperforms the S&P 500's 18.35% gain, indicating relative strength. Short-term momentum is accelerating: the 1-month price change is +10.1% and the 3-month change is +29.5%, both outpacing the S&P 500's 0.31% and 4.67% respectively. This acceleration aligns with the longer-term uptrend, confirming strong buying pressure. The relative strength index (RSI) is not provided, but the consistent upward price action suggests bullish sentiment. The stock's 52-week low of $73.21 provides key support, while the 52-week high of $140.42 is immediate resistance. A breakout above $140.42 would signal a continuation of the uptrend, potentially targeting new highs. Conversely, a breakdown below $73.21 would indicate a bearish reversal. With a beta of 1.549, Crocs is 54.9% more volatile than the market, meaning larger price swings and higher risk for position sizing.
Beta
1.55
1.55x market volatility
Max Drawdown
-32.5%
Largest decline past year
52-Week Range
$73-$140
Price range past year
Annual Return
+28.7%
Cumulative gain past year
| Period | CROX Return | S&P 500 |
|---|---|---|
| 1m | +8.3% | -0.6% |
| 3m | +26.1% | +5.4% |
| 6m | +58.8% | +8.3% |
| 1y | +28.7% | +18.3% |
| ytd | +55.7% | +8.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CROX Fundamental Analysis
Revenue in the most recent quarter (Q1 2026) was $921.5 million, down 1.7% year-over-year, following a pattern of deceleration from Q2 2025's $1,149.4 million (which included a large impairment). The Crocs Brand segment generated $767.4 million in revenue, while HEYDUDE contributed $154.0 million, indicating the core brand is the primary driver. The multi-quarter trend shows revenue declining from $1,149.4M in Q2 2025 to $957.6M in Q4 2025 and $921.5M in Q1 2026, suggesting a slowdown that investors are watching closely. Net income in Q1 2026 was $137.6 million, with a net margin of 14.9%, a recovery from the loss in Q2 2025 (-$492.3 million) but below the 17.1% margin in Q1 2025. Gross margin was 56.8% in Q1 2026, slightly below the 57.8% in Q1 2025, indicating modest compression. Operating margin improved to 21.8% from 23.8% a year ago, showing operational discipline despite revenue headwinds. The company has a debt-to-equity ratio of 1.25, indicating moderate leverage, and a current ratio of 1.27, suggesting adequate liquidity. Free cash flow over the trailing twelve months was $670.7 million, demonstrating strong cash generation. However, in Q1 2026, free cash flow was negative at -$71.1 million due to working capital changes. Return on equity (ROE) was -6.3% on a trailing basis due to the Q2 2025 loss, but the most recent quarter's ROE was positive at 9.6%.
Quarterly Revenue
$921457000.0B
2026-03
Revenue YoY Growth
-1.7%
YoY Comparison
Gross Margin
56.8%
Latest Quarter
Free Cash Flow
$670662000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CROX Overvalued?
Since net income is positive (TTM net income of $137.6 million in Q1 2026), the primary valuation metric is the P/E ratio. The trailing P/E is -57.0 due to the Q2 2025 loss, but the forward P/E is 9.4x, indicating the market expects normalized earnings. The gap between trailing and forward P/E reflects the one-time impairment in Q2 2025. Compared to the industry average P/E (not provided), Crocs' forward P/E of 9.4x appears low, suggesting a discount. The PEG ratio of 0.52 implies the stock is undervalued relative to its expected earnings growth. Historically, Crocs' trailing P/E has ranged from 4.3x (Q4 2024) to 15.7x (Q1 2022). The current forward P/E of 9.4x is near the lower end of this range, indicating the stock is trading at a discount to its historical average. This could represent a value opportunity if earnings growth materializes, but it may also reflect skepticism about the HEYDUDE turnaround.
PE
-57.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~16x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Crocs carries a debt-to-equity ratio of 1.25, indicating moderate leverage that could strain cash flows if earnings deteriorate. The Q1 2026 free cash flow was negative $71.1 million due to working capital changes, a sharp reversal from the TTM figure of $670.7 million, highlighting potential cash flow volatility. Net margin declined to 14.9% in Q1 2026 from 17.1% a year ago, and gross margin compressed to 56.8% from 57.8%, suggesting cost pressures or mix shifts. Revenue concentration in the Crocs Brand (83% of total) and the underperforming HEYDUDE segment (17%) creates single-brand risk, as any brand fatigue could materially impact results.
Market & Competitive Risks: The stock's forward P/E of 9.4x is a discount to its historical average, but the implied downside to the average analyst target of $126 suggests the market may already be pricing in risks. With a beta of 1.549, Crocs is highly sensitive to macroeconomic shifts, and a recession could compress consumer discretionary spending. Competitive threats from other casual footwear brands (e.g., Skechers, Birkenstock) could erode market share, especially if HEYDUDE fails to differentiate. Recent news highlights the HEYDUDE overhang, and any negative headlines could trigger further analyst downgrades.
Worst-Case Scenario: If HEYDUDE continues to struggle and overall revenue declines accelerate, the stock could fall to the 52-week low of $73.21, representing a 46.6% decline from the current price of $137.13. This scenario would likely involve a recession or a failed turnaround, leading to multiple compression and earnings misses. The analyst low target of $86 implies a 37.3% downside, while the historical max drawdown of 32.54% suggests similar magnitude. An investor could lose up to 47% in a severe adverse scenario.
FAQ
The primary risk is the HEYDUDE brand turnaround failing, which could lead to further impairments and revenue declines. Financial risks include a debt-to-equity ratio of 1.25 and negative free cash flow in Q1 2026 (-$71.1M). Market risks include high beta (1.55), making the stock vulnerable to macro downturns. Competitive risks from other footwear brands could erode market share. The most severe risk is a 46% decline to the 52-week low of $73.21 if the turnaround fails and a recession hits.
The 12-month outlook is balanced: a 25% probability of a bull case reaching $140-$150 (driven by HEYDUDE turnaround), a 50% probability of a base case around $120-$130 (flat to slight downside), and a 25% probability of a bear case falling to $86-$100 (if HEYDUDE deteriorates or macro weakens). The base case is most likely, with the stock trading near the analyst average target of $126. Key assumptions include stable Crocs brand performance and no major macro shocks.
Based on forward P/E of 9.4x, CROX appears undervalued relative to its historical range of 4.3x-15.7x and the industry average. The PEG ratio of 0.52 further supports undervaluation. However, the average analyst target of $126 suggests the stock is slightly overvalued at current levels, implying an 8% downside. The market is pricing in skepticism about HEYDUDE and revenue growth, but the low multiple may already reflect these risks. Overall, CROX is likely fairly valued to slightly undervalued on an earnings basis, but the market expects a recovery that has not yet materialized.
CROX offers a compelling value proposition with a forward P/E of 9.4x and a PEG ratio of 0.52, suggesting it is undervalued relative to expected earnings growth. However, the average analyst target of $126 implies 8% downside from the current price of $137, and revenue is declining 1.7% YoY. For value investors with a long-term horizon and tolerance for volatility (beta 1.55), CROX could be a good buy if they believe in the HEYDUDE turnaround. For growth-oriented investors, the lack of top-line momentum may be a concern. The biggest downside risk is a 46% decline to the 52-week low of $73 if the turnaround fails.
CROX is better suited for long-term investment given its low valuation and strong cash flow, but it requires patience due to the HEYDUDE turnaround uncertainty. The stock's high beta (1.55) and recent strong momentum (up 28.6% in 1 year) make it volatile for short-term trading. A minimum holding period of 12-18 months is recommended to allow the turnaround story to play out. Short-term traders may find opportunities around earnings, but the wide analyst target range ($86-$150) indicates high uncertainty.
